相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Noor Momin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
Qingnan Zhao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cytokines in Cancer Immunotherapy
Thomas A. Waldmann
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
Jiemiao Hu et al.
CLINICAL CANCER RESEARCH (2018)
IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy
Jianmin Zhu et al.
JCI INSIGHT (2018)
Interleukin-27 signalling induces stem cell antigen-1 expression in T lymphocytes invivo
Zhihao Liu et al.
IMMUNOLOGY (2017)
Targeting Immune Checkpoints in Cancer Therapy
Suzanne L. Topalian
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1
Shin Foong Ngiow et al.
CANCER RESEARCH (2015)
Potential clinical application of interleukin-27 as an antitumor agent
Takayuki Yoshimoto et al.
CANCER SCIENCE (2015)
Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
Ling Zhang et al.
CLINICAL CANCER RESEARCH (2015)
The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy
Ming-Song Li et al.
IMMUNOTHERAPY (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
JOURNAL OF IMMUNOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
IL-27 enhances the survival of tumor antigen-specific CD8+T cells and programs them into IL-10-producing, memory precursor-like effector cells
Zhenzhen Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
Katarzyna Franciszkiewicz et al.
CANCER RESEARCH (2012)
The Cytokines Interleukin 27 and Interferon-γ Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology
Aisling O'Hara Hall et al.
IMMUNITY (2012)
Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1
Kiyoshi Hirahara et al.
IMMUNITY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
T-bet's ability to regulate individual target genes requires the conserved T-box domain to recruit histone methyltransferase activity and a separate family member-specific transactivation domain
Megan D. Lewis et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Interleukin-12: Biological properties and clinical application
Michele Del Vecchio et al.
CLINICAL CANCER RESEARCH (2007)
T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects
KM Beima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells
S Kamiya et al.
JOURNAL OF IMMUNOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-Bet and IL-12Rβ2 in naive T cells
L Hibbert et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
分享论文
